Study of Culturelle in the Prophylaxis of Infection and Diarrhea
Phase 2
Terminated
- Conditions
- Pediatric Burns
- Registration Number
- NCT01605747
- Lead Sponsor
- Shriners Hospitals for Children
- Brief Summary
The primary objective of this study is to determine if probiotic prophylaxis has immunologic and gastrointestinal advantages in pediatric burn patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- acute burn injury
- consented within 10 days of injury
- feeding tube present-
Exclusion Criteria
- GI disorder prior to burn
- milk allergy or insensitivity
- non-burned
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Infectious outcome 3 years Record incidence of infection between the experimental and placebo groups.
- Secondary Outcome Measures
Name Time Method Clinical outcome 3 years Plan to measure clinical outcome between the experimental and placebo groups.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie probiotic effects on immune function in pediatric burn patients?
How does Lactobacillus rhamnosus GG compare to standard-of-care for preventing infections in burn patients?
Are there specific gut microbiome biomarkers that predict probiotic efficacy in pediatric burns?
What adverse events are associated with long-term probiotic use in immunocompromised children?
What combination therapies with Culturelle show promise for gastrointestinal protection in burn injuries?
Trial Locations
- Locations (1)
Shriners Hospital for Children
🇺🇸Cincinnati, Ohio, United States
Shriners Hospital for Children🇺🇸Cincinnati, Ohio, United States